Management of Patients Presenting to Primary Care Settings with Suspected Colorectal Cancer

Objectives

Guide primary care doctors and family physicians to recognise, assess and refer people with suspected colorectal cancer, while promoting risk reduction and earlier detection. Early-stage diagnosis is associated with markedly better survival, with five-year survival reported as 90% at an early stage compared with less than 8% at an advanced stage.[1][2]

• Identify people at increased risk by considering modifiable factors, including overweight or obesity, physical inactivity, diets high in red or processed meat and fat, smoking, and heavy alcohol use.[3][4]
• Recognise non-modifiable risk factors, including older age, previous colorectal polyps or cancer, inflammatory bowel disease, family history, inherited cancer syndromes, and type 2 diabetes.[4][2]
• Promote protective lifestyle factors, including physical activity; fibre and whole grains; fruit and vegetables; dairy products, milk and calcium; folate; and vitamin D.[2]
• Direct people identified as being at risk towards screening or further investigation, while noting that no established national colorectal cancer screening programme is described.[3][2][5]
• Prioritise timely specialist assessment for suspected cancer before local extension beyond the bowel wall or metastasis, when outcomes are substantially less favourable.[1]

Implementation

Deliver a risk-based primary-care pathway built around clinical history, physical examination, initial investigations, documentation and timely referral to tertiary surgical or gastroenterology services. Risk identification may occur through outpatient departments, healthy lifestyle clinics, well-women clinics and general practitioners.[1][2][5]

• Classify average-risk people as those aged over 50 years without a history of adenoma or hamartoma, inflammatory bowel disease, or a positive family history.[5]
• Assess suspected cases through comprehensive history-taking and physical examination, including abdominal examination and compulsory digital rectal examination.[5]
• Record relevant general and digestive symptoms, including appetite loss, fatigue, unexplained weight loss, rectal bleeding, persistent changes in bowel habit, incomplete evacuation, abdominal discomfort, mucus in stools and bloating, alongside family history.[5]
• Undertake a full blood count, particularly haemoglobin measurement, and use faecal occult blood testing where there is no obvious per-rectal bleeding; low haemoglobin or a positive result should prompt further investigation.[5]
• Refer high-risk patients without delay to a tertiary surgical or gastroenterology clinic, and refer average-risk patients with suspected symptoms, as well as people of any age with unexplained suspicious symptoms, signs or investigation findings, for specialist care.[5]
• Use digital rectal examination with consent and left lateral positioning, inspecting and palpating the anal canal and rectal walls for masses, polyps, thickening, ulcers or blood, and examining the prostate or pouch of Douglas where relevant.[6]
• Use proctoscopy where appropriate to visualise the distal 5–8 centimetres of the rectum and assess mucosal changes, haemorrhoids, polyps and ulcers.[6]
• Use the sample referral form to document symptoms and duration, family, medical, social, dietary and drug history, examination findings, available investigations, haemoglobin and faecal occult blood results.[1][6]
• Remain alert to benign conditions such as haemorrhoids that may mimic cancer, while recognising that colorectal cancer can occur without per-rectal bleeding.[5]

The supplied material does not specify named implementing institutions, governance arrangements, workforce requirements, budgets, financing mechanisms, performance indicators, reporting schedules, surveillance systems, audit processes or accountability arrangements.[1][5][7][6]

Monitoring & Evaluation

No formal monitoring, evaluation, reporting, surveillance, audit or accountability framework is specified. The material instead provides clinical evidence and referral documentation that could support case assessment and follow-up.[1][3][5][7][6]

• Use epidemiological evidence on colorectal cancer incidence, mortality, risk factors and stage-specific survival to support the rationale for earlier detection and referral. Early-stage diagnosis is associated with reported five-year survival of 90%, compared with less than 8% at an advanced stage.[1][3][4][2]
• Identify clinical findings requiring further investigation or specialist referral, including low haemoglobin, a positive faecal occult blood test, high-risk status, and unexplained symptoms or signs suggestive of colorectal cancer.[5]
• Document referral-relevant information through the sample referral form, including symptoms and duration, rectal bleeding, bowel-habit changes, family and medical history, examination findings, available investigation results, haemoglobin and faecal occult blood test results.[6]
• Record assessment findings from digital rectal examination and, where undertaken, proctoscopy, including masses, polyps, wall thickening, ulcers, blood and mucosal changes.[6]
• Recognise that the source does not establish programme indicators, targets, data flows, reporting frequency, responsible reporting entities, surveillance arrangements, evaluation methods, audit processes or accountability mechanisms.[1][2][5][7][6]

Costing & Financing

No costing or financing framework is provided for colorectal cancer risk assessment, testing, referral, specialist care, screening, monitoring or implementation.[1][3][4][2][5][7][6]

• Specify no programme budget, activity-level cost, unit cost, expenditure allocation, financing source, donor contribution, funding gap or resource-mobilisation mechanism.[1][2][5][7][6]
• Provide no economic assumptions, cost-effectiveness analysis, affordability assessment, currency-denominated amount or implementation timeframe linked to financing.[3][4][5][7][6]
• Describe clinical resources and procedures, including full blood count testing, faecal occult blood testing, digital rectal examination, proctoscopy and referral to tertiary surgical or gastroenterology services, but do not attach costs or funding arrangements to them.[5][6]
• Note that no established national colorectal cancer screening programme is described, without specifying the financial implications or resource requirements of establishing one.[2][5]